POLE Deficiency Exacerbates Diesel Engine Exhaust‐Induced Genomic Instability and Malignant Transformation of Bronchial Epithelial Cells
Source abstract
Abstract
Abstract Diesel engine exhaust (DEE) is classified as a Group I carcinogen, yet direct experimental evidence that DEE induce carcinogenesis is lacking. Here, it is innovatively discovered that 120 µg mL −1 DEE exposure for 20 weeks, original bronchial epithelial cells exhibit abnormal morphology, form colonies in soft agar, and readily develop the lumps under the subcutaneous tissue of immunodeficient mice, which are pathologically confirmed as lung squamous cell carcinoma. Whole genome sequencing and RNA sequencing identify DEE‐induced mutational signatures (DBS3, ID1/ID2), associated with polymerase epsilon (POLE) exonuclease domain mutations and mismatch repair (MMR) deficiency. Besides, 52 exonic mutations, 734 copy number variations (CNVs), and 2519 differentially expressed genes (DEGs) are discovered which are enriched in the suppressed DNA damage repair pathways and the activated lung cancer related signaling pathways including JAK‐STAT, PI3K‐Akt, MAPK in the DEE‐induced malignant transformed cells. Further assays confirm DEE‐induced malignant transformed cells harbor both POLE and MMR defects, leading to high mutation burden and genomic instability. Additionally, POLE deficiency exacerbates DEE‐induced DNA damage and genomic instability, promoting the cell malignant transformation. This study highlights the importance of gene‐environment interaction in carcinogenesis and emphasizes the critical role of POLE deficiency in DEE‐induced malignant transformation of lung cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Occupational and environmental lung diseases · Carcinogens and Genotoxicity Assessment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Blood Transfusion The Affiliated Hospital of Qingdao University Qingdao University Qingdao Shandong 266000 China
School of Public Health Qingdao University Qingdao Shandong 266021 China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Shandong Province
References (80)
Show source-provided references
1. F. Painting IARC Monographs on the Evaluation of Carcinogenic Risks to Humans WHO Geneva2012.
2. 10.1016/j.envint.2020.10550610.1016/j.envint.2020.105506 ↗
3. 10.1186/s12992-024-01040-010.1186/s12992-024-01040-0 ↗
4. 10.1097/EE9.000000000000006110.1097/EE9.0000000000000061 ↗
5. 10.3390/ijerph1806325810.3390/ijerph18063258 ↗
6. 10.1016/j.ijheh.2023.11429910.1016/j.ijheh.2023.114299 ↗
7. 10.1289/ehp.719510.1289/ehp.7195 ↗
8. 10.1111/cas.1350510.1111/cas.13505 ↗
9. 10.1038/nature1247710.1038/nature12477 ↗
10. 10.1093/nar/gky101510.1093/nar/gky1015 ↗
11. 10.1038/s12276-023-01030-z10.1038/s12276-023-01030-z ↗
12. 10.1038/s41598-021-94064-010.1038/s41598-021-94064-0 ↗
13. 10.1021/acs.est.2c0809210.1021/acs.est.2c08092 ↗
14. 10.1038/s41467-018-04002-410.1038/s41467-018-04002-4 ↗
15. 10.1038/s41588-021-00930-y10.1038/s41588-021-00930-y ↗
16. 10.1002/path.537210.1002/path.5372 ↗
17. 10.1038/s41436-020-0922-210.1038/s41436-020-0922-2 ↗
18. 10.1016/j.ygyno.2024.01.01810.1016/j.ygyno.2024.01.018 ↗
19. 10.1016/j.jbc.2022.10183110.1016/j.jbc.2022.101831 ↗
20. 10.3389/fonc.2021.64001810.3389/fonc.2021.640018 ↗
21. 10.1016/j.asjsur.2023.12.17610.1016/j.asjsur.2023.12.176 ↗
22. 10.1200/JCO.20.0054910.1200/JCO.20.00549 ↗
23. 10.1126/sciadv.add856410.1126/sciadv.add8564 ↗
24. 10.1021/acs.est.5b0049910.1021/acs.est.5b00499 ↗
25. 10.1016/j.ccell.2020.11.00210.1016/j.ccell.2020.11.002 ↗
26. 10.3390/ijerph1803104610.3390/ijerph18031046 ↗
27. 10.1126/science.113667810.1126/science.1136678 ↗
28. 10.1016/j.molcel.2018.01.02810.1016/j.molcel.2018.01.028 ↗
29. 10.1101/cshperspect.a02645010.1101/cshperspect.a026450 ↗
30. 10.1371/journal.pgen.100851410.1371/journal.pgen.1008514 ↗
31. 10.1371/journal.pgen.101114810.1371/journal.pgen.1011148 ↗
32. 10.1016/j.bcp.2021.11486410.1016/j.bcp.2021.114864 ↗
33. 10.3390/cancers1416405510.3390/cancers14164055 ↗
34. 10.1016/j.drup.2022.10090810.1016/j.drup.2022.100908 ↗
35. 10.31138/mjr.231123.jia10.31138/mjr.231123.jia ↗
36. 10.3390/pharmaceutics1508209010.3390/pharmaceutics15082090 ↗
37. 10.3390/ijms2216888510.3390/ijms22168885 ↗
38. 10.3390/ijms22221225410.3390/ijms222212254 ↗
39. Lin H. · J. Environ. Occupat. Med. · 2023 · 40 · 529
40. Henkler F. · Exp. Suppl. · 2012 · 101 · 107
41. 10.1016/j.envpol.2022.12019410.1016/j.envpol.2022.120194 ↗
42. 10.1016/j.envint.2024.10892810.1016/j.envint.2024.108928 ↗
43. 10.1155/2013/68403510.1155/2013/684035 ↗
44. 10.1016/j.envint.2019.10494310.1016/j.envint.2019.104943 ↗
45. 10.1038/s41586-023-05874-310.1038/s41586-023-05874-3 ↗
46. 10.1016/j.envpol.2022.12098110.1016/j.envpol.2022.120981 ↗
47. 10.1021/acs.est.3c0065310.1021/acs.est.3c00653 ↗
48. 10.1007/s10654-017-0268-510.1007/s10654-017-0268-5 ↗
49. 10.1164/rccm.201911-2101OC10.1164/rccm.201911-2101OC ↗
50. 10.1002/advs.20220689610.1002/advs.202206896 ↗
51. 10.1038/s41586-020-1943-310.1038/s41586-020-1943-3 ↗
52. 10.1038/s41586-020-1961-110.1038/s41586-020-1961-1 ↗
53. 10.1126/science.aag029910.1126/science.aag0299 ↗
54. 10.1093/nar/gkad61110.1093/nar/gkad611 ↗
55. 10.1093/oncolo/oyae09110.1093/oncolo/oyae091 ↗
56. 10.1126/sciadv.adh308310.1126/sciadv.adh3083 ↗
57. 10.1016/j.cell.2019.02.01210.1016/j.cell.2019.02.012 ↗
58. 10.1038/s43018-021-00200-010.1038/s43018-021-00200-0 ↗
59. 10.1038/s41598-023-32499-310.1038/s41598-023-32499-3 ↗
60. 10.1002/cam4.234410.1002/cam4.2344 ↗
61. 10.3390/cancers1311270910.3390/cancers13112709 ↗
62. 10.1038/nature1211310.1038/nature12113 ↗
63. 10.1111/j.1742-4658.2006.05190.x10.1111/j.1742-4658.2006.05190.x ↗
64. 10.1038/s41467-019-11760-210.1038/s41467-019-11760-2 ↗
65. 10.1016/j.lungcan.2018.02.00410.1016/j.lungcan.2018.02.004 ↗
66. 10.1186/s13046-022-02422-110.1186/s13046-022-02422-1 ↗
67. 10.1136/jitc-2021-00279710.1136/jitc-2021-002797 ↗
68. 10.1016/j.modpat.2024.10042310.1016/j.modpat.2024.100423 ↗
69. 10.1038/nrm285810.1038/nrm2858 ↗
70. Yao Y. · J. Carcinog. Mutagen. · 2014 · 5
71. 10.1111/1759-7714.1501210.1111/1759-7714.15012 ↗
72. 10.3389/fphar.2022.81726510.3389/fphar.2022.817265 ↗
73. 10.1126/science.aaa134810.1126/science.aaa1348 ↗
74. 10.1001/jamaoncol.2019.296310.1001/jamaoncol.2019.2963 ↗
75. 10.1016/j.jhazmat.2024.13554210.1016/j.jhazmat.2024.135542 ↗
76. 10.1016/j.ecoenv.2024.11640110.1016/j.ecoenv.2024.116401 ↗
77. 10.1289/ehp.02110s345110.1289/ehp.02110s3451 ↗
78. Shimada T. · Drug Metab. Dispos. · 2001 · 29 · 1176
79. 10.1289/ehp.110375010.1289/ehp.1103750 ↗
80. 10.1016/j.ccell.2020.11.00410.1016/j.ccell.2020.11.004 ↗